2025年4月18日 周五
Home > Archive>Volume 25, Issue 4, 2017 >411-416
PDF HTML XML Export Cite reminder
Exosome provides a new intervention target for atherosclerosis
CSTR:
[cstr]
Author:
Affiliation:

Institute of Cardiovascular Disease Research & Key Laboratory for Atherosclerology of Hunan Province, University of South China, Hengyang, Hunan 421001, China)

Clc Number:

R363

  • Article
    • | |
  • Metrics
    • |
  • Reference [36]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Atherosclerosis is a chronic inflammatory disease. The objective of the clinical use of anti-atherosclerotic drugs is to decrease circulating low density lipoprotein level, increase high density lipoprotein level, and reduce inflammation. However, the morbidity and mortality of cardiovascular disease remain high. Therefore, the identification of unknown therapeutic targets and the development of new anti-atherosclerotic drugs is growing. Exosome is a kind of membrane vesicles derived from late nuclear endosome (also known as polycystic body) secreted by living cells. Exosome contains protein, rRNA, and micro RNA, which are related to the source cells, and it can pass the biological barrier and produce various biological functions. Exosome is expected to become a novel drug delivery pathway and gene therapy vector for the treatment of atherosclerosis.

    Reference
    [1] Khatun Z, Bhat A, Sharma S, et al.Elucidating diversity of exosomes:biophysical and molecular characterization methods.Nanomedicine (Lond), 6,1(17):2 359-377.
    [2] Wahlgren J, Statello L, Skogberg G, et al.Delivery of small interfering RNAs to cells via exosomes.Methods Mol Biol, 6,4:105-125.
    [3] Fang DY, King HW, Li JY, et al.Exosomes and the kidney:blaming the messenger.Nephrology (Carlton), 3,8(1):1-10.
    [4] Yin M, Loyer X, Boulanger CM.Extracellular vesicles as new pharmacological targets to treat atherosclerosis.Eur J Pharmacol, 5,3(Pt A):90-103.
    [5] Peterson MF, Otoc N, Sethi JK, et al.Integrated systems for exosome investigation.Methods, 5,7:31-45.
    [6] Kanwar SS, Dunlay CJ, Simeone DM, et al.Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes.Lab Chip, 4,4(11):1 891-900.
    [7] Hoefer IE, Steffens S, Ala-Korpela M, et al.Novel methodologies for biomarker discovery in atherosclerosis.Eur Heart J, 5,6(39):2 635-642.
    [8] Boulanger CM, Scoazec A, Ebrahimian T, et al.Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.Circulation, 1,4(22):2 649-652.
    [9] Segura E, Nicco C, Lombard B, et al.ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming.Blood, 5,6(1):216-223.
    [10] Kapustin AN, Chatrou ML, Drozdov I, et al.Vascular smooth muscle cell calcification is mediated by regulated exosome secretion.Circ Res, 5,6(8):1 312-323.
    [11] Hergenreider E, Heydt S, Treguer K, et al.Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs.Nat Cell Biol, 2,4(3):249-256.
    [12] Krychtiuk KA, Kastl SP, Speidl WS, et al.Inflammation and coagulation in atherosclerosis.Hamostaseologie, 3,3(4):269-282.
    [13] Bretz NP, Ridinger J, Rupp AK, et al.Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling.J Biol Chem, 3,8(51):36 691-702.
    [14] Aharon A, Tamari T, Brenner B.Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells.Thromb Haemost, 8,0(5):878-885.
    [15] Zhang Y, Liu D, Chen X, et al.Secreted monocytic miR-150 enhances targeted endothelial cell migration.Mol Cell, 0,9(1):133-144.
    [16] Liu ML, Scalia R, Mehta JL, et al.Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns:mechanisms of formation, action, and detoxification.Arterioscler Thromb Vasc Biol, 2,2(9):2 113-121.
    [17] Deng ZB, Poliakov A, Hardy RW, et al.Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance.Diabetes, 9,8(11):2 498-505.
    [18] Janiszewski M, Do Carmo AO, Pedro MA, et al.Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity:A novel vascular redox pathway.Crit Care Med, 4,2(3):818-825.
    [19] Gambim MH, do Carmo Ade O, Marti L, et al.Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation:experimental evidence for a novel mechanism of septic vascular dysfunction.Crit Care, 7,1(5):R107.
    [20] Zakharova L, Svetlova M, Fomina AF.T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor.J Cell Physiol, 7,2(1):174-181.
    [21] Bossi G, Griffiths GM.Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells.Nat Med, 9,5(1):90-96.
    [22] Munich S, Sobo-Vujanovic A, Buchser WJ, et al.Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands.Oncoimmunology, 2,1(7):1 074-083.
    [23] Barry OP, Pratico D, Savani RC, et al.Modulation of monocyte-endothelial cell interactions by platelet microparticles.J Clin Invest, 8,2(1):136-144.
    [24] Srikanthan S, Li W, Silverstein RL, et al.Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions.J Thromb Haemost, 4,2(11):1 906-917.
    [25] Rezeli M, Gidlof O, Evander M, et al.Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.Anal Chem, 6,8(17):8 577-586.
    [26] Palma J, Yaddanapudi SC, Pigati L, et al.MicroRNAs are exported from malignant cells in customized particles.Nucleic Acids Res, 2,0(18):9 125-138.
    [27] Ragusa M, Barbagallo C, Statello L, et al.miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients:Pathological and diagnostic implications.Cancer Biol Ther, 5,6(9):1 387-396.
    [28] Gallo A, Tandon M, Alevizos I, et al.The majority of microRNAs detectable in serum and saliva is concentrated in exosomes.PLoS One, 2,7(3):e30 679.
    [29] Suades R, Padro T, Alonso R, et al.Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells.Thromb Haemost, 3,0(2):366-377.
    [30] Hamilos M, Muller O, Ntalianis A, et al.Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel.J Thromb Thrombolysis, 1,2(1):64-71.
    [31] Jernberg T, Payne CD, Winters KJ, et al.Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease.Eur Heart J, 6,7(10):1 166-173.
    [32] Rossig L, Hoffmann J, Hugel B, et al.Vitamin C inhibits endothelial cell apoptosis in congestive heart failure.Circulation, 1,4(18):2 182-187.
    [33] Chan S, Chen MP, Cao JM, et al.Carvedilol protects against iron-induced microparticle generation and apoptosis of endothelial cells.Acta Haematol, 4,2(2):200-210.
    [34] Thind A, Wilson C.Exosomal miRNAs as cancer biomarkers and therapeutic targets.J Extracell Vesicles, 6,5:31 292.
    [35] Chistiakov DA, Orekhov AN, Bobryshev YV.Extracellular vesicles and atherosclerotic disease.Cell Mol Life Sci, 5,2(14):2 697-708.
    [36] Gaceb A, Martinez MC, Andriantsitohaina R.Extracellular vesicles:new players in cardiovascular diseases.Int J Biochem Cell Biol, 4,0(1):24-28.
    Cited by
Get Citation

JIANG Yue, TIAN Meng-Xiang, WANG Shuang, YI Guang-Hui. Exosome provides a new intervention target for atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2017,25(4):411-416.

Copy
Share
Article Metrics
  • Abstract:1544
  • PDF: 1263
  • HTML: 0
  • Cited by: 0
History
  • Received:September 17,2016
  • Revised:November 03,2016
  • Online: May 18,2017
Article QR Code

You are the 32720 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025